Clinical Utility of Circulating Tumour Cell Androgen Receptor Splice Variant-7 Status in Metastatic Castration-resistant Prostate Cancer. (2019)
Attributed to:
BAG-1: A novel strategy for targeting the androgen receptor splice variants in castrate resistant prostate cancer.
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1016/j.eururo.2019.04.006
PubMed Identifier: 31036442
Publication URI: http://europepmc.org/abstract/MED/31036442
Type: Journal Article/Review
Volume: 76
Parent Publication: European urology
Issue: 5
ISSN: 0302-2838